Science named the HIV thwarting Trials Network (HPTN) 052 study "Breakthrough of the Year." FHI 360 congratulates our HPTN 052 collaborating partners on this historic achievement. This is the second year in a row that Science selected a trial for which FHI 360 in the case that scientific primacy and operational support. Last year, the CAPRISA 004 study was orthodox as one of Science's breakthroughs of 2010. "To have our work, and that of our collaborators, be mentioned on this prestigious list two years running is incredibly exciting," said FHI 360's stewards of Research, Dr. Ward Cates...

More: - From the site